SOFIA (Bulgaria), April 18 (SeeNews) – U.S. investment funds Gramercy Select Master Fund and Gramercy Emerging Markets Fund have sold their stakes in Bulgarian blue-chip drug maker Sopharma [BUL:3JR], the Sofia-based company said on Wednesday.